Guanadrel

This classification denotes an antihypertensive agent with the molecular formula C10H19N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 765C9332T4, chemically known as (1,4-dioxaspiro(4.5)dec-2-ylmethyl)guanidine but generally known as guanadrel, which bears US NIH Compound Identifier 38521. European Medicines Agency schedules Guanadrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07980MIG. The term GUANADREL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). GUANADREL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guanadrel under HS 29329970 and SITC 51569. As of Q4 2014, GUANADREL remains the US FDA Preferred Term for this commodity. Guanadrel bears US NLM identifiers UMLS ID C0061938 and NCI Concept Code C65827. SMILES: C1CCC2(CC1)OCC(O2)CN=C(N)N.